Get started
Author

Alison G. Barber

Observed names: Alison Barber, Alison G Barber, Barber, Alison G.
ORCID: 0000-0001-8308-9327
Observed ORCID: 0000-0001-8308-9327
OpenAlex ID: A5074932422
Stem cell fate in cancer growth, progression and therapy resistance
2018 · Nikki K. Lytle, Alison G. Barber, et al. · Nature reviews. Cancer · 669
Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer
2014 · Alison G. Barber, Mireia Castillo-Martin, et al. · PLoS ONE · 56
PDF
Mutations in R-Spondin 4 (RSPO4) Underlie Inherited Anonychia
2007 · Yoshiyuki Ishii, Muhammad Wajid, et al. · Journal of Investigative Dermatology · 54
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49
PDF
PI 3K/ AKT pathway regulates E‐cadherin and Desmoglein 2 in aggressive prostate cancer
2015 · Alison G. Barber, Mireia Castillo‐Martin, et al. · Cancer Medicine · 44
PDF
Desmoglein 4 is regulated by transcription factors implicated in hair shaft differentiation
2009 · Hisham Bazzi, Shadmehr Demehri, et al. · Differentiation · 39
Striate palmoplantar keratoderma resulting from a frameshift mutation in the desmoglein 1 gene
2006 · Alison G. Barber, Muhammad Wajid, et al. · Journal of Dermatological Science · 28
Genetic linkage studies in autosomal recessive retinitis pigmentosa
1994 · David Mansfield, Peter Teague, et al. · The American Journal of Human Genetics · 5
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
2024 · Alison G Barber, Cynthia M Quintero, et al. · eLife · 2
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
2025 · Alison G Barber, Cynthia M Quintero, et al. · eLife · 1
PDF
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
2024 · Alison G Barber, Cynthia M Quintero, et al. · eLife · 1
Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis
2026 · Ryan A. Adams, Ying-Ting Wang, et al. · Journal of Biological Chemistry
Abstract 4791: Immunosuppressive myeloid cells can be modulated with NRP2-targeting antibody ATYR2810 leading to enhanced anti-tumor immunity
2025 · Christoph Burkart, Clara Polizzi, et al. · Cancer Research
Author response: Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
2025 · Alison G Barber, Cynthia M Quintero, et al. · eLife
Author response: Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
2024 · Alison G Barber, Cynthia M Quintero, et al. · eLife
Abstract 1758: Resistance to cancer therapy via upregulation of the NRP2/VEGF-C axis can be neutralized by ATYR2810
2023 · Alison Barber, Zhiwen Xu, et al. · Cancer Research
Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy
2022 · Zhiwen Xu, Alison Barber, et al. · Cancer Research
Abstract LB234: The Neuropilin-2 targeting antibody ATYR2810 inhibits non-small cell lung cancer tumor growth in monotherapy and combination therapy
2021 · Alison G. Barber, Zhiwen Xu, et al. · Cancer Research
Abstract A01: Stem cell signals in the initiation and progression of non-small cell lung cancer
2018 · Alison G. Barber, Hatim Husain, et al. · Clinical Cancer Research
Examining the Role and Regulation of Cell-Cell Adhesion in Aggressive Prostate Cancer
2011 · Barber, Alison G.
Works count: 20
Citation count: 948
H-index: 7
I10-index: 7
Year
Topic
Type